Evidence map›Paper›PMID 40760252›Full record

ArticleDiabetologia2025

What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers.

Amalie K Andersen, Kristian D Lyng, Kristine Færch, Dorte Vistisen, Bernt J von Scholten, Michael S Rathleff, Janus L Thomsen, Morten H Jensen

Abstract read
In one paragraph

Article in Diabetologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amalie K AndersenDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark. amalieka@hst.aau.dk.ORCID http://orcid.org/0009-0005-3983-8681
Kristian D LyngDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0001-8668-691X
Kristine FærchData Science, Novo Nordisk A/S, Søborg, Denmark.ORCID http://orcid.org/0000-0002-6127-0448
Dorte VistisenData Science, Novo Nordisk A/S, Søborg, Denmark.ORCID http://orcid.org/0000-0001-5045-5351
Bernt J von ScholtenDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0002-1489-0636
Michael S RathleffDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-1173-0335
Janus L ThomsenCenter for General Practice at Aalborg University, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0002-0745-6815
Morten H JensenDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0002-6649-8644

Funding

Danish Data Science Academy NNF21SA0069429Danish Diabetes and Endocrine Academy NNF22SA0079901
6 · The paper itself

Abstract

aims/hypothesisResearch agendas are typically set by researchers and funders, meaning that priorities of end users, such as patients and healthcare professionals (HCPs), could be missed or overlooked in research. To ensure future research in prediabetes is of relevance and benefit to people with prediabetes and HCPs, it is important to involve these stakeholders in setting the research agenda. The aim of this study was to establish a top-10 list of the most important research questions in prediabetes (HbA

methodsWe used a modified James Lind Alliance Priority Setting Partnership methodology, following the four-step process including: (1) Gathering uncertainties; (2) Organising uncertainties; (3) Interim priority setting; and (4) Final priority setting in a workshop. Further, the international relevance of the final top-10 list was assessed.

resultsA total of 1142 responses were submitted by 405 people to: 'What questions about prediabetes would you like to see answered by research?'. The collected uncertainties were categorised and condensed into 35 indicative questions. Through prioritisation, patients and relatives had different preferences from researchers and HCPs. The jointly agreed top-10 list included questions on prevention strategies, risk factors, diet advice, screening and personalised treatment. Highest prioritisation was given to: 'What is the best prevention of diabetes and will early prevention strategies reduce the number of people with type 2 diabetes?'. CONCLUSIONS/

interpretationAn iterative and collaborative process identified shared priorities between patients, HCPs and relevant stakeholders in prediabetes. Findings should support academia, funders and the healthcare industry to target research within prediabetes specifically to the needs of patients and HCPs.

Indexed as

Health PersonnelPrediabetic StateAdultCooperative BehaviorFemaleHumansMaleMiddle AgedResearch PersonnelPatient and public involvementPrediabetesResearch priorities

Identifiers

PMID40760252
PMCPMC12423201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.